AAV2-hRPE65 gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AAV2-hRPE65 gene therapy, covering 2018-04-10 to 2018-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations [Phase 1]